Tradestie Institutional Equity Comparison Engine

FGEN vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-02-11 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, FGEN trades at 61.4x Forward P/E with -499.1% operating margin (+774.8% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, FGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
FGEN 61.4x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner AVDL
Op Margin -499.1% vs 2.5% ยท YoY +774.8% vs +54.9%
Momentum & Technical Winner AVDL
1Y -28.8% vs +138.1% ยท 52W Pos 44% vs 89%
Options & Structure Winner AVDL
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
FGEN NASDAQ
FibroGen, Inc
Pharmaceutical Preparations
$9.71
+7.65% 1D
Market Cap $36.5M
1M Return +16.57%
1Y Return -28.84%
Forward P/E 61.4x
Unified AI Score
61.2 / 100 BUY
Tech 60.0 Fund 56.0 Flow 50.0 Mom 60.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FGEN -28.84% AVDL +138.06% Spread: +158.57 pp (AVDL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FGEN TTM Op. Margin: -499.1% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FGEN vs AVDL. Trailing 12-month operating profitability (FGEN -499.1% vs AVDL 2.5%) and valuation multiples (FGEN 61.4x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FGEN (2) vs AVDL (8)
Institutional Metric FGEN AVDL Criterion Row Winner
Market Capitalization Scale $36.5M $2.1B Larger Scale AVDL
Trailing P/E Ratio Valuation 61.4x 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation 61.4x 28.8x Lower Multiple AVDL
Revenue Growth (YoY) Growth +774.8% +54.9% Higher Growth FGEN
Operating Margin (TTM) Profitability -499.1% 2.5% Higher Margin AVDL
Net Profit Margin Profitability 2598.9% -0.1% Higher Margin FGEN
Return on Equity (ROE) Capital Efficiency -1015.8% -0.3% Higher ROE AVDL
52-Week Range Position Momentum 44% ($0โ€“$22) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime -20.79ฮฒ ยท 102% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 61.2 / 100 (BUY) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FGEN vs AVDL Buy Guide
FGEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FGEN nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.